28
total announcements
AHCL.NS · 15 min delayed
Anlon Healthcare Limited
Anlon Healthcare Limited has submitted the voting results of its 13th Annual General Meeting, where 11 resolutions were passed, including the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026.
Anlon Healthcare Limited
Anlon Healthcare Limited held its 13th Annual General Meeting on September 05, 2025, through video conference, where the company's financial performance and operations were discussed, and members raised questions to the board.
Anlon Healthcare Limited
Anlon Healthcare Limited has issued a corrigendum to its notice of annual general meeting (AGM) to be held on September 05, 2026, in response to observations raised by BSE and NSE regarding its in-principle application for issue and allotment of shares on a preferential basis.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication for the 13th Annual General Meeting to be held on September 05, 2026.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026, to consider and adopt audited financial statements for the financial year ended March 31, 2026, and to appoint a director and non-executive & independent director.
Anlon Healthcare Limited
Anlon Healthcare Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of IPO proceeds. The report states that there was a deviation from the objects stated in the Prospectus, but it was in line with the change of objects approved by shareholders. The company has expanded the scope of the object to include inorganic growth and upgradations.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange that Record date for the purpose of Annual General Meeting is 28-Aug-2026. The company's Board of Directors has approved several matters, including the Audited Standalone Financial Statements, appointment of a director, regularization of a Non-Executive & Independent Director, appointment of an Internal Auditor, and approval of remuneration of Cost Auditor. The company has also approved the increase in authorized share capital and the adoption of share swap agreements with Apiqo Organics Private Limited and Bizotic Lifescience Private Limited.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026. The Board considered and approved various matters, including audited financial statements, appointment of a director, regularization of another director, appointment of an internal auditor, remuneration of cost auditor, increase in authorized share capital, and adoption of share swap agreements for acquiring up to 44.94% and 47.41% shareholding in two private companies.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about a revised intimation regarding the acquisition of shares in Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, correcting the percentage of acquisition from 32.52% to 44.94% and 43.33% to 47.41% respectively.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about the transcript of the Q1 FY27 Earnings Conference call, which was held on August 6, 2026. The company's EBITDA margin moderated to approximately 17% due to a sharp increase in raw material prices and the consolidation of Remember India Health links' operating expenses. The company expects EBITDA margins to gradually recover and stabilize in the 25% to 30% range during Q2 and Q3 of FY27. The company has completed the acquisition of a 63.98% stake in Remember India Health links, which provides access to over 30 formula dossiers.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about the Share Swap Agreement (SSA) with Apiqo Organics Private Limited and Bizotic Lifescience Private Limited to acquire up to 32.52% and 43.33% shareholding respectively in lieu of issuance and allotment of fresh equity shares on a preferential basis.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about the link of recording for the Q1/FY-27 Earnings Conference Call with Investor(s)/Analyst(s). The audio recording is available on the company's website.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about Investor Presentation for Q1 & FY - 27, which is uploaded on their website. The presentation includes information on the company's transformational acquisitions, capacity expansion, and growth prospects.
Anlon Healthcare Limited
Anlon Healthcare Limited has published its unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 725 million.
Anlon Healthcare Limited
Anlon Healthcare Limited has informed the Exchange about a scheduled earnings conference call to discuss the audited Financial Results for the Quarter ended June 30, 2026.
Anlon Healthcare Limited
Anlon Healthcare Limited has reported a 163% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150% growth in EBITDA to ₹15.65 Crore, and 133% growth in Profit After Tax to ₹8.28 Crore for Q1FY27.
Anlon Healthcare Limited
Anlon Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors also approving the acquisition of 32.52% shareholding in Apiqo Organics Private Limited and 43.33% shareholding in Bizotic LifeScience Private Limited through a share swap arrangement.
Anlon Healthcare Limited
Anlon Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved a share swap arrangement with Apiqo Organics Private Limited and Bizotic LifeScience Private Limited to acquire 32.52% and 43.33% shareholding in these entities respectively.
Anlon Healthcare Limited
Anlon Healthcare Limited has submitted a Structured Digital Database (SDD) Compliance Certificate for the quarter ended June 30, 2026, as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.